Synthetic piperidine-substituted chalcones as potential hits for α-amylase inhibitory and antioxidant activities

Future Med Chem. 2023 Mar;15(6):497-515. doi: 10.4155/fmc-2022-0317. Epub 2023 Apr 24.

Abstract

Background: In medicinal chemistry, searching for new therapeutic entities to treat diabetes mellitus is of great concern. The piperidinyl-substituted chalcone scaffold has piqued our interest as a potential antidiabetic agent. Methods: A variety of piperidinyl-substituted chalcones 2-28 were synthesized and tested for α-amylase inhibitory and 2,2-diphenyl-1-picrylhydrazyl and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical-scavenging activities. Results: Compared with the standard acarbose, all compounds inhibited α-amylase, with IC50 values of 9.86-35.98 μM. Docking studies revealed an important binding interaction with the enzyme's catalytic site. The compounds also demonstrated promising radical-scavenging potential against 2,2-diphenyl-1-picrylhydrazyl and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radicals. Conclusion: This study has identified potential lead candidates for further advanced research searching for antidiabetic agents.

Keywords: chalcone; docking studies; piperidine; radical scavengers; α-amylase inhibition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants* / chemistry
  • Antioxidants* / pharmacology
  • Chalcones* / pharmacology
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology
  • Sulfonic Acids
  • alpha-Amylases / metabolism

Substances

  • Antioxidants
  • 1,1-diphenyl-2-picrylhydrazyl
  • Chalcones
  • alpha-Amylases
  • Hypoglycemic Agents
  • diphenyl
  • Sulfonic Acids